Product Information
HYDRALAZINE 50 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.0445 per EA under NDC 64380073508. Its NADAC has been published 634 times since May 14, 2014.
FDA first approved this application on May 3, 2013. Its Orange Book therapeutic-equivalence code is AA.
Strength
50 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380073508
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDRALAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA200770FDA Approved
5/3/2013
TE Code
AA
On Market Since
6/30/2013
Pharmacological Classes
Price Statistics
The NADAC for HYDRALAZINE 50 MG TABLET has been published 634 times since May 14, 2014, and over the history we have for it it has declined 55.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0445 per EA |
|---|---|
| All-time high | $0.1047 (Aug 20, 2014) |
| All-time low | $0.0343 (Nov 20, 2024) |
| 52-week high | $0.0475 |
| 52-week low | $0.0445 |
| Median price | $0.0525 |
| Average price | $0.0580 |
| Largest weekly change | -28.1% (Nov 20, 2024) |
| Weeks tracked | 634 |
| Tracking since | May 14, 2014 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strides Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
HydrALAZINE Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Arteriolar Vasodilator class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HYDRALAZINE 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYDRALAZINE 50 MG TABLET, manufactured by Strides Pharma Inc., is $0.0445 per EA (NDC 64380073508), effective Sep 30, 2026.
How has the price of HYDRALAZINE 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for HYDRALAZINE 50 MG TABLET has declined 55.9%. It has been tracked across 634 weekly CMS publications since May 14, 2014.
What are the highest and lowest recorded NADAC prices for HYDRALAZINE 50 MG TABLET?
Since May 14, 2014, the NADAC for HYDRALAZINE 50 MG TABLET has ranged from a low of $0.0343 (Nov 20, 2024) to a high of $0.1047 (Aug 20, 2014), with a median of $0.0525 per EA.
Are there cheaper alternatives to HYDRALAZINE 50 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as HYDRALAZINE 50 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures HYDRALAZINE 50 MG TABLET?
HYDRALAZINE 50 MG TABLET (NDC 64380073508) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.